Carmignac Gestion

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1569758 PARIS, I0

Position in REGN

as of Mar 31, 2026 · filed Jun 15, 2026 Compact

Position Value

$90,067,417

+$51,496,302 QoQ

Shares Held

116,571

+133.3% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

1.38%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Carmignac Gestion holds $218,566,713 across 10 Biotechnology names. REGN ranks #1 (41.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	116,571	$90,067,417
2	VRTX	Vertex Pharmaceuticals Inc / Ma	148,199	$66,176,781
3	RPRX	Royalty Pharma plc	631,200	$30,278,664
4	FOLD	AMICUS THERAPEUTICS, INC.	784,508	$11,343,985
5	BNTX	BioNTech SE	112,711	$10,017,753
6	IONS	Ionis Pharmaceuticals Inc	53,000	$3,979,770
7	TERN	Terns Pharmaceuticals, Inc.	53,541	$2,822,681
8	ACLX	Arcellx, Inc.	18,925	$2,172,968

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$90,067,417	116,571	+133.3%	Shares	Sole	2026-06-15
2025-12-31	$38,571,115	49,971	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.